PTGS2 and colorectal carcinoma: In summary, in this study, we analysed the effect of NS398 selective COX2 inhibitor treatment on colorectal adenoma- and CRC-associated gene expression alterations using whole-genomic mRNA expression microarrays and the HT29 colon adenocarcinoma cell line.